首页|华蟾素胶囊联合NX方案化疗治疗晚期乳腺癌患者的临床疗效及对免疫功能的影响

华蟾素胶囊联合NX方案化疗治疗晚期乳腺癌患者的临床疗效及对免疫功能的影响

扫码查看
目的 探讨华蟾素胶囊联合长春瑞滨+卡培他滨(NX)方案化疗治疗晚期乳腺癌患者的临床疗效及对免疫功能的影响.方法 根据治疗方式的不同将91例晚期乳腺癌患者分为对照组(45例)和观察组(46例),对照组患者接受NX方案化疗,观察组患者在对照组的基础上接受华蟾素胶囊治疗.比较两组患者的临床疗效、肿瘤标志物[糖类抗原15-3(CA15-3)、癌胚抗原(CEA)]、免疫功能指标(CD3+、CD4+、CD8+、CD4+/CD8+)、不良反应及预后情况.结果 观察组患者的治疗总有效率高于对照组,神经毒性、骨髓抑制、胃肠道反应发生率均低于对照组,无进展生存期(PFS)、总生存期(OS)均长于对照组,差异均有统计学意义(P﹤0.05).治疗后,两组患者CEA、CA15-3、CD8+水平均降低,CD3+、CD4+水平及CD4+/CD8+均升高,观察组患者CEA、CA15-3、CD8+水平均低于对照组,CD3+、CD4+水平及CD4+/CD8+均高于对照组,差异均有统计学意义(P﹤0.05).结论 华蟾素胶囊联合NX方案化疗治疗晚期乳腺癌患者疗效较好,可提高免疫功能,降低肿瘤标志物水平,减少化疗药物的不良反应,延长患者生存时间.
Clinical efficacy of Huachansu capsule combined with NX regimen chemotherapy in the treatment of patients with advanced breast cancer and its effect on immune function
Objective To investigate the clinical efficacy of Huachansu capsule combined with vinorelbine+capecitabine(NX)regimen chemotherapy in the treatment of patients with advanced breast cancer and its effect on im-mune function.Method According to different treatment methods,91 patients with advanced breast cancer were divided into control group(45 cases)and observation group(46 cases).The control group received NX regimen chemotherapy,and the observation group received Huachansu capsule treatment on the basis of the control group.The clinical efficacy,tumor markers[carbohydrate antigen 15-3(CA15-3),carcinoembryonic antigen(CEA)],immune function indicators(CD3+,CD4+,CD8+,CD4+/CD8+),adverse reactions and prognosis were compared between the two groups.Result The total effective rate in observation group was higher than that in control group,the incidences of neurotoxicity,bone mar-row suppression and gastrointestinal reactions were lower than those in control group,and the progression-free survival(PFS)and overall survival(OS)were longer than those in control group,the differences were statistically significant(P<0.05).After treatment,the levels of CEA,CA15-3 and CD8+were decreased in both groups,the levels of CD3+,CD4+and CD4+/CD8+were increased,the levels of CEA,CA15-3 and CD8+in observation group were lower than those in control group,the levels of CD3+,CD4+and CD4+/CD8+were higher than those in control group,and the differences were statisti-cally significant(P<0.05).Conclusion Huachansu capsule combined with NX regimen chemotherapy is effective in the treatment of advanced breast cancer patients,which can improve the immune function,reduce the levels of tumor mark-ers,reduce the adverse reactions of chemotherapy drugs,and prolong the survival time of patients.

advanced breast cancerchemotherapyHuachansu capsuleclinical efficacyimmune functionadverse reaction

渠雅、仝振江、陈丽芳

展开 >

河南中医药大学第三附属医院 药学部,郑州 450000

河南中医药大学第三附属医院 肿瘤科,郑州 450000

晚期乳腺癌 化疗 华蟾素胶囊 临床疗效 免疫功能 不良反应

2024

癌症进展
中国医学科学院,北京协和医学院

癌症进展

影响因子:1.004
ISSN:1672-1535
年,卷(期):2024.22(21)